RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MESSINA C
Collezione AO Ordine Mauriziano

Items : 6

Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2024 Jul 2;73(9):161. doi: 10.1007/s00262-024-03741-2.

2024
AO Ordine Mauriziano

Messina C; Catalano M; Roviello G; Gandini A; Maruzzo M; De Giorgi U; Pedrazzoli P; Sbrana A; Zucal PA; Masini C; Naglieri E; Procopio G; Milella M; Catalano F; Fratino L; Pipitone S; Ricotta R; Panni S; Mollica V; Soraru M; Prati V; Atzori F; Di Napoli M; Messina M; Morelli F; Prati G; Nole F; Malgeri A; Tudini M; et alii...

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. in ESMO open / ESMO Open. 2022 Oct;7(5):100575. doi: 10.1016/j.esmoop.2022.100575. Epub 2022 Sep 22.

2022
AO Ordine Mauriziano
AOU Novara

Cattrini C; Mennitto A; Maiello E; Altavilla A; Messina C; Roviello G; De Giorgi U; Maiorano BA; Di Maio M;

Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter three-year follow-up study from the Italian Minimally Invasive Treatment of the Thyroid (MITT) Group. in European radiology / Eur Radiol. 2022 Mar;32(3):1738-1746. doi: 10.1007/s00330-021-08289-8. Epub 2021 Nov 9.

2022
AO Ordine Mauriziano

Spiezia S; Solbiati LA; Presciuttini F; Palermo A; Persani L; Offi C; Negro R; Mormile A; Monti S; Messina C; Greco G; Gambelunghe G; Fugazzola L; Deandrea M; De Feo P; Cesareo R; Barbaro D; Bernardi S; Papini E; Mauri G; Stacul F; Viganò M; Sconfienza LM;

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Procopio G; Verzoni E; De Braud FG; Pignata S; Ottini A; Guadalupi V; Claps M; Sepe P; Stellato M; Buttigliero C; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Sorarù M; Santini D; Casadei C; Buti S; De Giorgi U; Mennitto A; Zattarin E; Di Maio M; Bimbatti D;

Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)". in International journal of cancer / Int J Cancer. 2022 Dec 15;151(12):2291-2292. doi: 10.1002/ijc.34246. Epub 2022 Sep 5.

2022
AO Ordine Mauriziano

Cattrini C; Messina C; Mennitto A; Di Maio M; Gennari A; Olmos D;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano

Bersanelli M; Casadei C; Pierantoni F; Roviello G; Cavo A; Vignani F; Nolè F; Prati G; Morelli F; Messina C; Messina M; Pignata S; Atzori F; Stellato M; Soto Parra HJ; Prati V; Santoni M; Cortellini A; Sorarù M; Mollica V; Panni S; Ricotta R; Baldessari C; Fratino L; Tomasello L; Merler S; Procopio G; Naglieri E; Masini C; et alii...